Comment
2024-03-05
Comment on Pharma Equity Group’s Notification from the EPO Granting Their Patent for the Drug Candidate RNX-022
Equity research report
2024-02-29
STENOCARE Q4-23
2024-02-27
Pharma Equity Group
2024-02-22
Comment on STENOCARE’s Year-end Report 2023
Video
2024-02-05
Interview with Pharma Equity Group’s CEO Thomas Kaas Selsø